Paper · 6973604
Purification of murine T cell growth factor. A lymphocyte mitogen with helper activity.
Granelli-Piperno A and 2 others. J Exp Med, 1981. Cited by 53 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Purification of murine T cell growth factor. A lymphocyte mitogen with helper activity. Papers, record 6973604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6973604
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interleukin-2 | Major topic |
| Lymphokines | Major topic |
| Animals | |
| Chromatography, Ion Exchange | |
| Dose-Response Relationship, Immunologic | |
| Electrophoresis, Polyacrylamide Gel | |
| Lymphocyte Activation | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Nude | |
| Sodium Dodecyl Sulfate |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA-08290 | NCI NIH HHS | United States | PubMed | |
| GM-07245 | NIGMS NIH HHS | United States | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6,034,749 | Immunization of dissociated spleen cell cultures from normal mice. | J Exp Med | 1967 | https://conductscience.org/library/papers/6034749 | PubMed |
| 2 | 6,450,803 | Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. I. Characterization of a soluble suppressor T cell proliferation. | J Immunol | 1981 | https://conductscience.org/library/papers/6450803 | PubMed |
| 3 | 4,592,599 | Biological expressions of lymphocyte activation. 3. Suppression of plaque-forming cell responses in vitro by supernatant fluids from concanavalin A-activated spleen cell cultures. | J Immunol | 1974 | https://conductscience.org/library/papers/4592599 | PubMed |
| 4 | 942,051 | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. | Anal Biochem | 1976 | https://conductscience.org/library/papers/942051 | PubMed |
| 5 | 833,546 | Macrophage plasminogen activator: induction by products of activated lymphoid cells. | J Exp Med | 1977 | https://conductscience.org/library/papers/833546 | PubMed |
| 6 | 303,772 | Activation of cytotoxic T cells by nonstimulating tumor cells and spleen cell factor(s). | Proc Natl Acad Sci U S A | 1977 | https://conductscience.org/library/papers/303772 | PubMed |
| 7 | 145,543 | Long term culture of tumour-specific cytotoxic T cells. | Nature | 1977 | https://conductscience.org/library/papers/145543 | PubMed |
| 8 | 310,827 | The purification and quantitation of helper T cell-replacing factors secreted by murine spleen cells activated by concanavalin A. | J Immunol | 1979 | https://conductscience.org/library/papers/310827 | PubMed |
| 9 | 109,511 | Molecular and quantitative analysis of helper T cell-replacing factors on the induction of antigen-sensitive B and T lymphocytes. | J Immunol | 1979 | https://conductscience.org/library/papers/109511 | PubMed |
| 10 | 312,860 | Physicochemical characterization of lymphocyte-activating factor (LAF). | J Immunol | 1979 | https://conductscience.org/library/papers/312860 | PubMed |
1 to 10 of 18
See all 18 referencesCited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,980,256 | Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity. | J Exp Med | 1982 | https://conductscience.org/library/papers/6980256 | PubMed |
| 6,608,103 | Purification to homogeneity and partial characterization of interleukin 2 from a human T-cell leukemia. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6608103 | PubMed |
| 6,607,316 | Cytotoxic T cells both produce and respond to interleukin 2. | J Exp Med | 1984 | https://conductscience.org/library/papers/6607316 | PubMed |
| 6,601,512 | Growth inhibition of an MC-induced mouse sarcoma by TCGF (IL 2)-containing preparations. Preliminary report. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6601512 | PubMed |
| 6,417,263 | Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2. | J Exp Med | 1983 | https://conductscience.org/library/papers/6417263 | PubMed |
| 6,376,356 | In vivo and in vitro administration of interleukin 2-containing preparation reverses T-cell unresponsiveness in Mycobacterium bovis BCG-infected mice. | Infect Immun | 1984 | https://conductscience.org/library/papers/6376356 | PubMed |
| 6,334,715 | Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A. | J Exp Med | 1984 | https://conductscience.org/library/papers/6334715 | PubMed |
| 6,300,278 | Dendritic cells initiate a two-stage mechanism for T lymphocyte proliferation. | J Exp Med | 1983 | https://conductscience.org/library/papers/6300278 | PubMed |
| 6,236,276 | Antibodies to interleukin 2. Effects on immune responses in vitro and in vivo. | J Exp Med | 1984 | https://conductscience.org/library/papers/6236276 | PubMed |
| 6,228,520 | Suppressor cells induced by BCG release non-specific factors in vitro which inhibit DNA synthesis and interleukin-2 production. | Immunology | 1984 | https://conductscience.org/library/papers/6228520 | PubMed |
1 to 10 of 16
See all 16 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6973604
GET https://conductscience.org/api/papers/v1/6973604/authors